Home > Insider Trading > Filing (0001437749-25-011068)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645469	Monopar Therapeutics	MNPR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1035909	J Michael Brown	C/O 598 Rockefeller Rd Lake Forest IL 60045		No	No	No	Yes
1727334	Chandler Robinson	1000 Skokie Blvd Suite 350 Wilmette IL 60091	Chief Executive Officer	Yes	Yes	No	No
1727357	Tactic Pharma Llc	C/O 598 Rockefeller Rd Lake Forest IL 60045		No	No	Yes	No
1727393	Paul Andrew Mazar	C/O 598 Rockefeller Rd Lake Forest IL 60045		No	No	No	Yes
1727481	V. Thomas O'halloran	C/O 598 Rockefeller Rd Lake Forest IL 60045		No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-04-02	33,334	$35.00	822,255	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.86, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.